0001104659-23-061938.txt : 20230517
0001104659-23-061938.hdr.sgml : 20230517
20230517170530
ACCESSION NUMBER: 0001104659-23-061938
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230515
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WG Biotech ApS
CENTRAL INDEX KEY: 0001753193
STATE OF INCORPORATION: G7
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38650
FILM NUMBER: 23932703
BUSINESS ADDRESS:
STREET 1: RUNGSTED STRANDVEJ 113
CITY: RUNGSTED KYST
STATE: G7
ZIP: 2960
BUSINESS PHONE: 45-45-17-77-77
MAIL ADDRESS:
STREET 1: RUNGSTED STRANDVEJ 113
CITY: RUNGSTED KYST
STATE: G7
ZIP: 2960
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Y-mAbs Therapeutics, Inc.
CENTRAL INDEX KEY: 0001722964
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474619612
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
BUSINESS PHONE: 212-847-9841
MAIL ADDRESS:
STREET 1: 230 PARK AVENUE
STREET 2: SUITE 3350
CITY: NEW YORK
STATE: NY
ZIP: 10169
4
1
tm2315932-2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4
2023-05-15
0
0001722964
Y-mAbs Therapeutics, Inc.
YMAB
0001753193
WG Biotech ApS
RUNGSTED STRANDVEJ 113
RUNGSTED KYST
G7
2960
DENMARK
1
0
0
1
See remarks
0
Common Stock
2023-05-15
4
P
0
101740
9.6462
A
4280205
D
This transaction was executed in multiple trades at prices ranging from $9.64 to $10.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff,the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Johan Wedell-Wedellsborg is the majority owner of WG Biotech ApS and has sole voting and dispositive power over the shares of the Issuer held by WG Biotech ApS. Mr. Wedell-Wedellsborg serves as a director of the Issuer. In connection therewith, WG Biotech ApS may be deemed to be a director by deputization of the Issuer solely for purposes of Section 16(a) of the Exchange Act. As a result, WG Biotech ApS is listed as a "Reporting Person" in Item 1 and the "Director" box is marked in Item 4 of this Form 4. This filing shall not be deemed an admission by Reporting Person on this Form 4 that such person is a director of the Issuer by deputization.
WG Biotech ApS By: /s/ Johan Wedell-Wedellsborg
2023-05-17